Table 3.
Patients’ laboratory data of Kawasaki disease before IVIG (with feet’s desquamation positive or not).
| Feet’s Desquamation Negative |
Feet’s Desquamation Positive |
p Value | Low-Grade Desquamation | High-Grade Desquamation | p Value | |
|---|---|---|---|---|---|---|
| Total | 39 | 63 | 54 | 9 | ||
| Male gender | 27/39 (69.2%) | 32/63 (50.8%) | 0.067 | 27/54 (50.0%) | 5/9 (55.6%) | 1.000 |
| Age | 1.1 (0.7–1.9) | 1.6 (0.7–2.5) | 0.185 | 1.6 (0.7–2.2) | 1.4 (1.1–3.6) | 0.327 |
| WBC (1000/mm3) | 11.3 (9.2–15.2) | 12.5 (10.5–14.4) | 0.610 | 12.3 (10.2–14.0) | 14.0 (12.8–17.0) | 0.033 * |
| Hemoglobulin (g/dL) | 11.3 (10.3–12.0) | 10.9 (10.2–11.7) | 0.484 | 10.9 (10.2–11.9) | 10.7 (10.2–11.7) | 0.746 |
| Platelet (1000/mm3) | 325.0 (255.0–431.0) | 375.0 (299.0–441.0) | 0.094 | 376.5 (297.3–442.3) | 371.0 (313.0–449.5) | 0.912 |
| Segmented WBC (%) | 56.2 (44.6–68.0) | 62.0 (51.0–72.0) | 0.300 | 61.0 (49.8–69.8) | 63.0 (58.4–74.3) | 0.249 |
| Band WBC (%) | 0 (0–0) | 0 (0–0) | 0.961 | 0 (0–0) | 0 (0–0) | 0.528 |
| Lymphocyte (%) | 29.7 (20.0–44.3) | 29.0 (21.2–39.0) | 0.498 | 28.5 (21.8–39.3) | 29 (16.9–33.3) | 0.539 |
| Monocyte (%) | 7.0 (3.8–10.0) | 4.7 (3.1–7.0) | 0.070 | 5.0 (3.4–7.9) | 4.0 (3.0–4.8) | 0.098 |
| CRP (mg/L) | 39.3 (14.1–67.6) | 58.3 (32.1–122.1) | 0.023 * | 58.3 (32.1–119.8) | 76.3 (29.3–179.7) | 0.845 |
| AST (IU/L) | 42.5 (32.3–93.5) | 34.0 (25.0–68.5) | 0.045 * | 34.0 (25.5–99.5) | 25.0 (21.0–47.0) | 0.155 |
| ALT (IU/L) | 34.5 (18.0–107.3) | 38.5 (17.0–74.3) | 0.635 | 47.5 (17.8–77.3) | 23.5 (14.0–71.0) | 0.495 |
| Albumin (g/dL) | 3.9 (3.5–4.3) | 4.0 (3.6–4.2) | 0.905 | 4.0 (3.6–4.2) | 4.0 (3.6–4.4) | 0.469 |
| Urine WBC (/μL) | 3.0 (0–34.0) | 6.0 (0–24.3) | 0.763 | 6.0 (0–21.8) | 4.5 (0–142.8) | 0.931 |
| IVIG resistant rate | 2/39 (5.1%) | 4/63 (6.3%) | 1.000 | 4/54 | 0/9 | 1.000 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; IVIG, intravenous immunoglobulin; WBC, white blood cells. * p < 0.05.